Concepedia

Simultaneous quantification of cannabinoids tetrahydrocannabinol, cannabidiol and CB1 receptor antagonist in rat plasma: An application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant

Abhigyan Ravula, Hardik Chandasana, Barry Setlow, Marcelo Febo, Adriaan W. Bruijnzeel, Hartmut Derendorf

Journal of Pharmaceutical and Biomedical Analysis · 2018 · 25 citations · 15 references

DOI

Concepts

References

15

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour

Serena Deiana, Akihito Watanabe, Yuki Yamasaki et al. · Psychopharmacology · 2011 · 401 citations

, , +7

Plasma Cannabinoid Pharmacokinetics following Controlled Oral Δ9-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration

Erin L Karschner, W. D. Darwin, Robert S. Goodwin et al. · Clinical Chemistry · 2010 · 226 citations · Full text

, , +12

Association of Inhalation Toxicologists (AIT) Working Party Recommendation for Standard Delivered Dose Calculation and Expression in Non-Clinical Aerosol Inhalation Toxicology Studies with Pharmaceuticals

David J. Alexander, Christopher J. Collins, Derek Coombs et al. · Inhalation Toxicology · 2008 · 215 citations

, , +13

Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity

Vicky Katsidoni, Andreas Kastellakis, George Panagis · The International Journal of Neuropsychopharmacology · 2013 · 105 citations · Full text

, , +17

Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats

Adriaan W. Bruijnzeel, Xiaoli Qi, Lidia Guzhva et al. · PLoS ONE · 2016 · 96 citations · Full text

, , +14